Golden Gate Private Equity’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,000
Closed -$970K 24
2018
Q2
$970K Sell
12,000
-38,000
-76% -$3.02M 0.59% 21
2018
Q1
$3.69M Hold
50,000
3.05% 14
2017
Q4
$3.52M Hold
50,000
2.96% 13
2017
Q3
$3.12M Hold
50,000
2.43% 18
2017
Q2
$2.87M Hold
50,000
1.47% 18
2017
Q1
$3.04M Sell
50,000
-28,200
-36% -$1.6M 1.3% 14
2016
Q4
$4.29M Sell
78,200
-319,823
-80% -$15.3M 1.68% 6
2016
Q3
$18.3M Sell
398,023
-250,000
-39% -$10.6M 8.21% 3
2016
Q2
$22.1M Buy
+648,023
New +$20.2M 11.98% 2

Other funds holding NGVT

Golden Gate Private Equity's NGVT Position: Q3 2018 in Review

Golden Gate Private Equity sold out of Ingevity (NGVT) in Q3 2018, closing a stake of 12,000 shares — an estimated $970K sold.

Golden Gate Private Equity first reported a position in NGVT in Q2 2016 and held it in 9 quarters. The position peaked at $22.1M in Q2 2016. 328 funds tracked by Wall St. Rank hold NGVT as of Q3 2018.

  • Golden Gate Private Equity reported no remaining Ingevity position as of Q3 2018 after selling out during the quarter.
  • Golden Gate Private Equity sold 12,000 Ingevity shares in Q3 2018, an estimated $970K.
  • Golden Gate Private Equity first reported a position in Ingevity in Q2 2016 and held it in 9 quarters.
  • Golden Gate Private Equity's Ingevity position peaked at $22.1M in Q2 2016.
  • 328 funds tracked by Wall St. Rank held Ingevity as of Q3 2018.

Based on Golden Gate Private Equity's 13F filing for Q3 2018, filed 14 Nov 2018.